TARS vs TER · rev $183.0M vs P/E 76, rev $2.82B
Tarsus Pharmaceuticals Inc (TARS) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported TARS revenue for 2024-12-31 was $183.0M. Net income was -$115.6M. Revenue was up 948.6% from 2023-12-31 to 2024-12-31. TARS currently screens at market cap $2.66B.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
TARS currently screens at market cap $2.66B. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the TARS and TER stock pages for the full models.
Not investment advice.